Latest News Archive

Please select Category, Year, and then Month to display items

UFS Thought-Leader series sparks national dialogue on employability and sustainability in higher education

18 June 2025 | Story Onthatile Tikoe | Photo Kaleidoscope Studios

Prof Hester C. Klopper, Vice-Chancellor and Principal of the UFS, will facilitate the UFS Thought-Leader Series discussion titled Reimagining Higher Education for Employability and Sustainability.

The University of the Free State (UFS) is proud to announce the next instalment of its prestigious Thought-Leader Series, titled Reimagining Higher Education for Employability and Sustainability. This highly anticipated event – held in collaboration with the Free State Arts Festival - will take place on Thursday, 17 July 2025, from 12:00 to 14:00 at the Albert Wessels Auditorium, UFS Bloemfontein Campus. Attendance is free and open to the public.

Now in its seventh year, the UFS Thought-Leader Series has established itself as a dynamic platform for robust public dialogue on pressing local and global issues. The series brings together influential voices from academia, industry, and civil society, reflecting the university’s continued commitment to thought leadership, public engagement, and transformative impact.

Rethinking the purpose of Higher Education

This year’s theme comes at a critical time. South Africa faces escalating youth unemployment, rapid technological change, and the complexities of a shifting global economy. Against this backdrop, questions around the purpose of higher education and its alignment with employability and sustainability have become increasingly urgent.

The panel will explore how universities can better integrate their teaching, research, and community engagement to address the real-world needs of graduates and society at large.

Prof Hester C. Klopper, Vice-Chancellor and Principal of the UFS, will serve as the facilitator. With her extensive leadership experience and academic expertise, she is well-positioned to guide what promises to be an insightful and forward-thinking conversation.

Meet the panellists

The session will feature an esteemed panel of thought leaders from the higher education landscape:

Dr Max Price

Former Vice-Chancellor of the University of Cape Town, Dr Max Price brings deep insights into leadership during transformative moments in South African higher education. A medical doctor and Rhodes Scholar, he holds postgraduate qualifications in public health. His recent memoir, Statues and Storms: Leading through change, reflects on steering a university through turbulent times and fostering dialogue on contested transformation issues.

Dr Phethiwe Matutu

As CEO of Universities South Africa (USAf), Dr Phethiwe Matutu leads national initiatives shaping the future of higher education. A mathematician by training, she has held strategic leadership roles at the National Research Foundation and the Department of Science and Technology. Her work is rooted in advancing equity, innovation, and access within the post-school education system.

Prof Paul E Green

Deputy Vice-Chancellor: Teaching and Learning at Sol Plaatje University, Prof Paul E Green is a specialist in systems thinking and higher education quality. Holding a PhD from the University of KwaZulu-Natal, he has served in senior academic positions across several institutions. His research centres on integrating education, innovation, and community impact to meet contemporary challenges.

Prof Pamela Dube

Prof Pamela Dube is the Vice-Chancellor and Principal of the Central University of Technology (CUT) - the first woman to be appointed to this role in the Free State. A distinguished academic and visionary leader with extensive global experience, she has served in senior positions across several universities and national institutions. Her work spans a wide range of fields, including student development, postcolonial studies, gender equity, and the evolving interface between technology and humanity. Known for her commitment to inclusive transformative education, Prof Dube has received numerous awards and international recognition for her contributions to higher education and leadership.

Event Details

Venue: Albert Wessels Auditorium, UFS Bloemfontein Campus

Date: Thursday, 17 July 2025

Time: 12:00–14:00 (90 minutes)

Click here to RSVP before 15 July 2025

News Archive

Nuclear Medicine on the forefront of cancer research

2017-07-10

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma. The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept